Page last updated: 2024-11-02

pamidronate and Hypertension

pamidronate has been researched along with Hypertension in 1 studies

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research Excerpts

ExcerptRelevanceReference
"Congenital mesoblastic nephroma is a rare pediatric renal tumor and has been reported in patients presenting with palpable abdominal mass, arterial hypertension, hematuria, polyuria, or hypercalcemia."1.72Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma: A case report and management of neonatal hypercalcemia: Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma. ( Bacchetta, J; Bordet, F; Dijoud, F; Duncan, A; Mure, PY; Pracros, JP; Tanné, C, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tanné, C1
Pracros, JP1
Dijoud, F1
Mure, PY1
Bordet, F1
Duncan, A1
Bacchetta, J1

Other Studies

1 other study available for pamidronate and Hypertension

ArticleYear
Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma: A case report and management of neonatal hypercalcemia: Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma.
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2022, Volume: 29, Issue:2

    Topics: Calcium; Female; Food, Fortified; Furosemide; Humans; Hypercalcemia; Hypertension; Infant Formula; I

2022